Skip to main content
. 2022 Jan 6;2022:8646314. doi: 10.1155/2022/8646314

Table 1.

Prevalence of PSA testing, reasons for having the test, and talks with healthcare professionals about the test according to race/ethnicity.

No. %1 White %1 Black %1 Asian %1 Am. Indian %1 Hispanic %1 Other %1 Rao–Scott Chi-square p-value
Ever had a PSA test
Yes 67620 45.3 49.0 44.8 30.8 34.3 33.3 38.4 <0.0001
No 62369 54.7 51.0 55.2 69.2 65.7 66.7 61.6
Missing 7630

PSA test in the past two years
Yes 45067 32.0 34.7 30.7 22.6 24.1 23.7 26.4 <0.0001
No 79203 68.0 65.3 69.3 77.4 75.9 76.3 73.6
Missing 1877

Reason for having a PSA test
Part of routine exam 47165 71.4 71.6 67.7 75.3 70.4 73.8 69.3 0.0005
Prostate problem 5174 7.6 7.2 8.0 9.0 6.9 9.1 7.5
Family history of p.c. 3869 5.8 6.2 5.7 4.4 7.3 4.2 4.2
Prostate cancer 3806 4.8 5.0 5.5 2.4 3.7 3.1 5.0
Other reasons 6725 10.4 10.1 13.1 9.0 11.7 9.8 14.1
Missing 881

Doctor, nurse, or other health professional ever talked with you about the benefits of the PSA test2
Yes 60594 43.7 47.10 45.76 34.19 34.31 29.81 37.52 <0.0001
No 62498 56.3 52.90 54.24 65.81 65.70 70.19 62.48
Missing 3091

Doctor, nurse, or other health professional ever talked with you about the harms of the PSA screennig2
Yes 27854 20.0 20.4 25.2 16.0 17.8 16.1 17.2 <0.0001
No 94709 78.0 79.6 74.8 84.0 82.2 83.9 82.8
Missing 3620

Doctor, nurse, or other health professionals ever recommend that you have a PSA screening2
Yes 56256 40.4 43.4 41.5 29.6 29.7 29.4 33.6 <0.0001
No 67050 59.6 56.6 58.5 70.4 70.3 70.6 66.4
Missing 2677

The results in this table apply to male respondents aged 40 years or older. 1Percentages are weighted in order to get a representative sample of the US population. 2Those who had a PSA test to monitor prostate cancer are not included.